Status:
COMPLETED
Analgesia From Conscious Sedation Versus Paracervical Block for Manual Vacuum Aspiration
Lead Sponsor:
Darlington-Peter Chibuzor Ugoji
Conditions:
Effect of Drug
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Miscarriage is one of the major causes of early pregnancy losses. Incomplete miscarriage is a major cause of maternal morbidity and mortality. Analgesia from both conscious sedation and paracervical c...
Detailed Description
SUMMARY Background: First trimester pregnancy losses are estimated to occur in 14-19% of all clinically confirmed pregnancies and account for about 80% of all the pregnancy losses. Miscarriage is on...
Eligibility Criteria
Inclusion
- \- Between the ages of 18- 45 years.
- Spontaneous incomplete miscarriage at less than 13 weeks.
- Not allergic to drugs for the study
- Patients that give consent
Exclusion
- \- Patients who do not consent to MVA \[ Manual vacuum aspiration\].
- Those with known allergy history to the drug agents.
- Those with septic incomplete miscarriage.
- Patients with infection at the cervical blocking sites.
- Those with active pelvic inflammatory disease.
- Patients with neurological or psychiatric disease.
- Incomplete miscarriage at greater than 13 weeks.
Key Trial Info
Start Date :
June 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 26 2023
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT06539143
Start Date
June 27 2023
End Date
September 26 2023
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AEFUTHA
Abakaliki, Ebonyi State, Nigeria, 480101